Company Filing History:
Years Active: 2014
Title: Innovations by Norbert Antal Kirschner: A Focus on Metabolites and Pharmaceuticals
Introduction: Norbert Antal Kirschner, an esteemed inventor based in Tata, Hungary, has made significant contributions to the field of pharmacology with his innovative work. With a patent to his name, he has expanded our understanding of metabolites and their pharmaceutical applications.
Latest Patents: Norbert holds a patent for "Metabolites of (thio) carbamoyl-cyclohexane derivatives." This invention dives into the metabolites of trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and their pharmaceutically acceptable salts. His work focuses on developing pharmaceutical compositions that utilize these metabolites in the treatment and prevention of conditions requiring modulation of dopamine receptors.
Career Highlights: Kirschner is associated with Richter Gedeon Nyrt., a prominent company known for its pharmaceutical innovations. His scientific expertise and contributions are crucial in advancing the company's research and development efforts, particularly in the domain of neurology and related fields.
Collaborations: Throughout his career, Norbert has collaborated with esteemed colleagues, including Eva Againe Csongor and Eva Schmidt. These partnerships emphasize the collaborative nature of innovation in pharmaceutical research, allowing for the sharing of knowledge and diverse perspectives.
Conclusion: Norbert Antal Kirschner's work exemplifies the intersection of innovative thinking and practical application in pharmaceuticals. His patent reflects a commitment to enhancing treatment options for conditions linked with dopamine receptor modulation. As he continues to work with his colleagues at Richter Gedeon Nyrt., the future looks promising for further advancements in this critical area of health science.